Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Fluorometholone adverse reaction |
Causative agent (attribute) |
True |
Fluorometholone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluorometholone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluorometholone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluorometholone allergy |
Causative agent (attribute) |
False |
Fluorometholone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluorometholone ophthalmic preparation |
Is a |
False |
Fluorometholone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluorometholone 1 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorometholone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing fluorometholone in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluorometholone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluorometholone acetate 0.1% suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorometholone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely fluorometholone 1 milligram/1 milliliter conventional release eye suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorometholone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluorometholone 0.1% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorometholone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely fluorometholone 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorometholone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluorometholone + sulfacetamide sodium 0.1%wv/10%wv suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorometholone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing fluorometholone and tobramycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluorometholone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tobramycin 0.3%/fluorometholone 0.1% ophthalmic suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorometholone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluorometholone allergy |
Causative agent (attribute) |
True |
Fluorometholone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluorometholone acetate |
Is a |
False |
Fluorometholone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluorometholone 1 mg/mL eye drops |
Has precise active ingredient |
True |
Fluorometholone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluorometholone 1 mg/mL eye drops |
Has basis of strength substance (attribute) |
True |
Fluorometholone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluorometholone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluorometholone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only fluorometholone and tobramycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluorometholone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only fluorometholone in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluorometholone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluorometholone acetate |
Is modification of (attribute) |
True |
Fluorometholone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely fluorometholone 1 milligram/1 milliliter conventional release eye suspension (clinical drug) |
Has basis of strength substance (attribute) |
True |
Fluorometholone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fluorometholone 1 milligram/1 milliliter conventional release eye suspension (clinical drug) |
Has precise active ingredient |
True |
Fluorometholone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fluorometholone 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) |
Has basis of strength substance (attribute) |
True |
Fluorometholone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fluorometholone 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) |
Has precise active ingredient |
True |
Fluorometholone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluorometholone + sulfacetamide sodium 0.1%wv/10%wv suspension |
Has precise active ingredient |
True |
Fluorometholone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Fluorometholone + sulfacetamide sodium 0.1%wv/10%wv suspension |
Has basis of strength substance (attribute) |
True |
Fluorometholone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Fluorometholone and tobramycin only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluorometholone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing fluorometholone and tobramycin in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluorometholone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluorometholone- and sulfacetamide-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluorometholone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only fluorometholone and sulfacetamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluorometholone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluorometholone- and sulfacetamide-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluorometholone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluorometholone and sulfacetamide only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluorometholone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |